[Bendamustine monotherapy for Chinese patient treatment with relapsed or refractory B cell non-Hodgkin lymphoma: a phase â
¡, prospective, multicenter, single-arm study].
Zhonghua Xue Ye Xue Za Zhi
; 43(11): 934-939, 2022 Nov 14.
Article
in Zh
| MEDLINE
| ID: mdl-36709185
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Bendamustine Hydrochloride
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2022
Document type:
Article